The results suggested that the expression of lipid metabolism–related genes can discriminate TAO patients with high LEPR expression from those with low LEPR expression and that genes such as ACADM, COL15A1 and ADH1C are up‐regulated in TAO patients with high LEPR expression. The gene discussed is ACADM; the disease is thromboangiitis obliterans.